Abstract
Identification of new drug targets may extend treatment options for neuroendocrine tumors (NET), regardless of histologic classification or primary organ site.
Publications
Profiling of 1,250 Neuroendocrine Tumors Identifies Multiple Potential Drug Targets
– Caris Life Sciences
Download Publication